For clinical research

Build and run a clinical NGS service, end to end.

From platform and assays to validated pipelines, reporting and support, we help hospital and reference laboratories bring genomic testing in-house with confidence.

Clinical test menu

Assays across the clinical workflow.

A representative menu we deploy and support. Method, sample type and indicative turnaround are shown for each; final menus are configured to your lab.

Regulatory status

This menu is representative of workflows Genique Lifesciences deploys and supports. Genique supplies platforms, kits and technical support, and separately provides bioinformatics analysis and sample-to-report services to institutional customers under written agreement. Sequencing is performed in NABL- and CAP-accredited laboratories using assays labelled Research Use Only. Laboratories remain responsible for the validation, accreditation and clinical use of any test they offer. Turnaround times are indicative.

Oncology (somatic)

Solid Tumour Profiling

SNV, indel, CNV and fusion detection across actionable solid-tumour genes.

Targeted NGS (CleanPlex · AVITI™ · SOPHiA DDM™) FFPE tissue TAT 7–10 days
Comprehensive Genomic Profiling (CGP)

Broad panel with TMB and MSI for therapy selection and trial matching.

Large-panel NGS FFPE · ctDNA TAT 10–14 days
Myeloid / Hematologic Panel

Diagnostic, prognostic and monitoring markers for myeloid malignancies.

Targeted NGS Peripheral blood · bone marrow TAT 7–10 days
Solid Tumour Hotspot

Fast, focused detection of common actionable hotspot variants.

Real-time PCR (Diatech) FFPE tissue TAT 3–5 days
HRD (Homologous Recombination Deficiency)

Identifies HRD-positive tumours to guide PARP-inhibitor eligibility.

Targeted NGS (genomic-instability score + BRCA1/2) FFPE tissue TAT 10–14 days

Liquid biopsy & monitoring

MRD (Minimal Residual Disease)

Detects residual and recurrent disease below imaging thresholds for post-treatment surveillance and treatment-response monitoring.

Tumour-informed ctDNA NGS (Gene Solutions K-TRACK · K-4CARE) Plasma TAT 10–14 days
Multi-Cancer Early Detection

Blood-based screening across multiple cancer types.

SPOT-MAS (Gene Solutions) Plasma TAT 10–14 days

Hereditary & rare disease

Hereditary Cancer Panel

Inherited cancer-risk genes, always counsellor-reviewed before release.

Germline NGS Blood · saliva TAT 10–14 days
Whole Exome / Clinical Exome

Diagnosis of rare and inherited disorders with phenotype-driven analysis.

WES (SOPHiA DDM™) Blood TAT 3–4 weeks
Carrier Screening

Recessive-condition carrier status for reproductive planning.

NGS · GSA Blood · saliva TAT 2–3 weeks

Reproductive

NIPT: triSure

Non-invasive prenatal screening for common aneuploidies.

cfDNA NGS (Gene Solutions) Maternal plasma TAT 7–10 days
Prenatal testing

Genique does not perform prenatal testing and does not receive, process or report on fetal samples. In compliance with the Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994, no test or technology supplied by Genique may be used to determine or disclose the sex of a fetus.

Pharmacogenomics

PGx Panel

Drug-metabolism genotyping across major drug classes to guide prescribing.

NGS · RT-PCR (Diatech) Blood · saliva TAT 7 days

Infectious disease & molecular

Molecular Detection Panels

Rapid nucleic-acid detection for infectious-disease targets.

Real-time PCR (Seasun U-TOP™ · AQ-TOP™) Swab · blood TAT 24–48 hrs
Support & service

We stay with your lab after go-live.

Instrument & application support

Field application and engineering teams in Gurugram, Bengaluru and Hyderabad, with defined response commitments.

Reagent supply & cold chain

Managed import, registration and cold-chain logistics to keep your assays running without interruption.

Bioinformatics & sign-out

Validated pipelines and interpretation support, with counsellor review available before release.

Accreditation readiness

Workflows aligned to CAP, ISO 15189 and NABL, with documentation support for your accreditation.

Evidence & validation

Decisions backed by data.

We support platform and assay adoption with analytical validation data, concordance studies with reputed institutions, and participation in external quality assessment. Validation dossiers and sample reports are available to your team on request.

Request lab documentation.

Ask us for panel spec sheets, a sample report or a validation dossier. Our clinical team will follow up.